Passage Bio’s CEO to Present at Prestigious Genetic Medicines Conference

Passage Bio

PHILADELPHIA, PA — Will Chou, M.D., the president and CEO of Passage Bio (NASDAQ: PASG), is set to present at Chardan’s 8th Annual Genetic Medicines Conference on October 1, 2024.

This notable event in New York City brings together leading innovators in genetic medicine. Attendees can expect engaging discussions, panels, and presentations from industry leaders, including companies like Ocugen and Fractyl Health.

For those unable to attend in person, a live webcast of Dr. Chou’s presentation will be available on Passage Bio’s website, with a replay accessible for 30 days after the event.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Dr. Martin Gershon to Deliver Keynote at 2024 Investor Capital Expo